Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (742)	12/20/2002 1:58:49 PM
From: Ken W	Respond to of 23958

Sergio In keeping with my frenzy I sold CLGY this morning at 4, from 3.60...I saw Gregory is buying more. Wonder if he is going to take the thing private since he is getting to a control point. I passed on ELP due to the latin america mess. I'm sure it will work out for you as you have the patience that I don't. LOL (wink) CDIC is getting so volitile that one can hardly not make money. Ken

To: Sergio H who wrote (742)	12/20/2002 6:59:26 PM
From: Sergio H	Respond to of 23958

GKM pushes short term target on CLGY up a notch. Report also states that Tostrex deal should come in early next year instead of the previously forecasted prior to the end of the year. <CLGY: reit` buy - TGT$6 from $5; Cellegy`s stock has performed well recently and we think that this will continue. We believe that this is due to significant and ongoing stock purchases by John Gregory, a founder of King Pharmaceuticals, and the expectation of a licensing deal early next year for Tostrex and US approval of Tostrex in 2Q03. A capital infusion of $5.5 million (through a PIPE transaction) by Mr. Gregory, has reduced investor concerns with corporate liquidity. Tostrex`s PDUFA date is April of 2003 suggesting approval at about that time.>